1) $JMP just announced earnings AMC, Thu, 18 Feb 21
Before getting started, note this is very thinly traded, and yet yesterday, before earnings announced post-market, it traded 32 x its normal avg volume. So, today, I think we're going to see some madness in this name.
2) In a normal setting, yesterday's candlestick, called a "hanging man" would suggest the next day would be down. However, as always, an Earnings report can change everything on a dime. So, today, I'll follow to see how this all pans out and see if volume goes 100x. My bet? UP.
3) That said, let's "do it"
600 Montgomery Street, Suite 1100
San Francisco, California jmpg.com
Sector: Financial
Industry: Investment Services
Employees: 209
4) DESCRIPTION
JMP Group LLC provides investment banking, sales and trading, and equity research services to corporate and institutional clients, and alternative asset management products and services to institutional investors and high net-worth individuals.
5) It operates through three segments: Broker-Dealer, Asset Management, and Investment. The Broker-Dealer segment includes underwriting and acting as a placement agent for public & private capital markets raising transactions, financial advisory services in M&A, restructuring
6) and other strategic transactions. The Asset Management segment involves in the management of pooled investment vehicles, including the company's hedge funds and collateralized loan obligations. The Investment segment includes Company’s principal investments in public
7) and private securities and investment funds managed by HCS, as well as any other net interest and income from investing activities, and interest expense related to the Company's bond issuance.
8) The company was founded by Joseph A. Jolson, Gerald L. Tuttle, Jr. and Carter D. Mack in 1999 and is headquartered in San Francisco, CA.
9) Summary as of 18 Feb 21
OPEN4.94
PREVIOUS CLOSE4.95
DAY RANGE4.39 - 4.98
52-WEEK RANGE2.15 - 4.98
ALL-TIME HIGH8.32
AVG. VOLUME (50-DAY)62,818
EPS (TTM)-1.03
NEXT EARNINGS DATE2/18/2021 (AMC)
LAST EARNINGS DATE10/28/2020
OPTIONSNo
10) Fundamentals
PRICE TO BOOK1.80
PRICE TO CASH FLOW-
PRICE TO FREE CASH FLOW-
TOTAL SALES (TTM)92.06 M
REVENUE PER SHARE (TTM)4.69
SHARES OUTSTANDING19.64 M
SHARE FLOAT (%)6.89 M (35.05%)
% HELD BY INSTITUTIONS17.16
12) No analyst upgrades/downgrades in years for this company, and there is almost no one shorting it. So, it's a micro-cap yawn. (I think this will change today.)
15) Again, I'm just pasting this together to see how this all works out today. I expect abnormal volume, higher highs, and loads of penny stock promoters jumping this. We shall see. This is a self-education moment for me and my developing hunches:
• • •
Missing some Tweet in this thread? You can try to
force a refresh
2) 4400 Biscayne Boulevard
Miami, Florida opko.com
Sector: Health Care
Industry: Biotechnology
Employees: 6,096
Note: I live in the FL Keys and have never heard of this firm with over 6,096 employees?
3) DESCRIPTION
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference,as well as . . .
2) 9975 Summers Ridge Road, Suite 200
San Diego, California quidel.com
Sector: Health Care
Industry: Medical Supplies
Employees: 1,250
3) DESCRIPTION
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions.
1) $PTON has turned bearish. A few days ago I was agnostic; now, were I trading this, I would have gone short this name two days ago. Extended trendline (thin line) shows busted horizontal and trendline support & trading under 50 day moving average.
2) Now that's just the chart look. The insider sales for $PTON since just last December (and especially in the past 10 days) tell you a story, and it is not bullish. Every time an insider vests options, they turn around and sell their shares. I don't see bullish buys here:
3) Be aware of product delays (chip shortages are real), and Buy Now Pay Later - although that is off-loaded to the firm Affirm (IIRC). Then, insider sales, and competition. $NLS and $LULU are not asleep during this exercise from home quarantine.
2) 3911 Sorrento Valley Boulevard, Suite 110
San Diego, California ligand.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
3) DESCRIPTION
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines.
1) Bulls vs. Bears Thread: A very bullish look: "The fact these extreme breadth readings keep pouring in as the rally progresses suggests we continue to be in a healthy market that is being driven by broadening participation." allstarcharts.com/february-confe…
2) "Most importantly, this is strong evidence that we are most likely at the beginning of a new bull market, not the end of an old one."
3) From the same link: "Speaking of this whole global growth and reflationary thesis we see playing out, here’s another development to add to the above list… New record highs for Emerging Markets $EEM." (Chart from All-Star Charts piece linked above.)